Sanlam flags rise in cancer-related claims, particularly for younger policyholders
Breast cancer claims increased by 33%, and prostate cancer claims soared by 41%, the insurer’s data for 2024 shows.
#Covid19
Medical schemes push ahead with case over Covid test pricing
The Competition Tribunal has dismissed key objections from major pathology laboratories, moving the medical schemes closer to having their damages claim heard in the High Court.
Landmark ruling by UK court in business interruption test case
South Africa’s courts have taken much guidance from the judgments emerging from the United Kingdom relating to Covid-19.
SCA clarifies when an insurance policy is a joint one
The appeal court also confirms the principles relating to the link between a notifiable disease and causation in respect of business interruption policies.
Sanlam flags increase in sickness and disability claims among younger policyholders
The group’s 2023 claim statistics also note the steady increase in pay-outs arising from pregnancy complications.
The global investment landscape four years after Covid
The long, painfully slow post-bubble recovery of the Japanese market forces us to ask whether there is a similar risk to the euphoria over AI.
